Abstract |
The purpose of this study was to compare the efficacy and safety of extended-release dexmethylphenidate (d-MPH-ER) to that of d,l-MPH-ER and placebo in children with attention-deficit/hyperactivity disorder ( ADHD) in a laboratory classroom setting. This multicenter, double-blind, crossover study randomized 82 children, 6 to 12 years of age, stabilized on a total daily dose to the nearest equivalent of 40 to 60 mg of d,l-MPH or 20 or 30 mg/day of d-MPH. Patients participated in a screening day and practice day, and were randomized to 1 of 10 sequences of all five treatments in five separate periods. Treatments included d-MPH-ER (20 mg/day), d-MPH-ER (30 mg/day), d,l-MPH-ER (36 mg/day), d,l-MPH-ER (54 mg/day), and placebo. Primary efficacy was measured by the change from predose on the Swanson, Kotkin, Agler, M-Flynn, and Pelham (SKAMP) Rating Scale-Combined scores at 2-h postdose during the 12-h laboratory assessment (d-MPH-ER 20 mg/day vs. d,l-MPH-ER 36 mg/day). Adverse events were monitored throughout the study period. d-MPH-ER (20 mg/day) was significantly more effective than d,l-MPH-ER (36 mg/day) in the primary efficacy variable, change from predose to 2-h postdose in SKAMP-combined score. In general, d-MPH-ER had an earlier onset of action than d,l-MPH-ER, while d,l-MPH-ER had a stronger effect at 12-h postdose. No serious adverse events were reported. Treatment with either agent was associated with significant improvements in ADHD symptoms. d-MPH-ER and d,l-MPH-ER can be differentiated on what part of the day each is more effective.
|
Authors | Raul Silva, Rafael Muniz, Kevin McCague, Ann Childress, Matthew Brams, Alice Mao |
Journal | Psychopharmacology bulletin
(Psychopharmacol Bull)
Vol. 41
Issue 1
Pg. 19-33
( 2008)
ISSN: 0048-5764 [Print] United States |
PMID | 18362868
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Central Nervous System Stimulants
- Delayed-Action Preparations
- Placebos
- Dexmethylphenidate Hydrochloride
- Methylphenidate
|
Topics |
- Area Under Curve
- Attention Deficit Disorder with Hyperactivity
(drug therapy)
- Central Nervous System Stimulants
(administration & dosage, adverse effects)
- Child
- Cross-Over Studies
- Delayed-Action Preparations
- Dexmethylphenidate Hydrochloride
- Double-Blind Method
- Female
- Humans
- Male
- Methylphenidate
(administration & dosage, adverse effects)
- Placebos
|